Twitter | Search | |
Search Refresh
The ICR 5m
💊 NEWS: A new clinical trial led by Professor has shown promising results for a new drug that could treat cancers including , gynaecological cancers and . Find out more ⤵️
Reply Retweet Like
Lung Cancer Canada Oct 26
NEW DATE! Join us! This episode is a moderated discussion of EGFR positive lung cancer that will include the beginning and evolution of treatment, current treatments, and what’s next. Dr. Tony Mok was just named a Giant of Cancer Care by OncLive®! Don't miss out!
Reply Retweet Like
ESMO - Eur. Oncology Oct 27
📣All currently-available 2020 Pocket Guideline PDFs now online & open access: multiple tumour types and topics for updates on , , , , , & more 👉
Reply Retweet Like
LUNGevity Foundation Oct 23
📣 Do you want to make a difference for those impacted by , but don’t know where to start? We’re excited to launch the LUNGevity Action Network, made for those with a passion for helping others. Check it out to start making a difference today.
Reply Retweet Like
LUNG FORCE Oct 27
If you have important questions about , our resources can help. Visit today.
Reply Retweet Like
clean kanmani Oct 26
You are praying for this man’s lungs? He has been pumping nicotine, alcohol and drugs into his system for years. Is mein hum Kya kare? Kisi par ghaslate daaloge toh aag toh lagegi hi na?
Reply Retweet Like
Sociedad Española de Citología Oct 27
Pleomorphism and atypical mitotic figures. Very illustrative pictures by Dr Lozano Thanks!
Reply Retweet Like
Fox Chase Cancer Center 6h
Join us on Nov. 5th for a discussion on . Fox Chase physicians and staff will be speaking about treatment advances, genetic testing, the latest research & support services available for those facing lung cancer. All are welcome! Register here: .
Reply Retweet Like
Landsberg Manual Oct 26
When your patient reports a history of PNA, ask them if they ‘knew’ they had pneumonia or if they were told they had pneumonia. People with typical bacterial PNA symptoms know they have PNA. Asymptomatic PNA is lung cancer until proven otherwise.
Reply Retweet Like
Gil Morgan 7h
The 🇺🇸has approved the FoundationOne Liquid CDx💉for use as a companion diagnostic for3️⃣targeted therapies ✅alpelisib in ✅rucaparib in advanced ✅alectinib in a type of metastatic
Reply Retweet Like
RoyCastle LungCancer Oct 27
We are delighted to receive funding from and to support our Ask the Nurse and Keep in Touch services, which have, and continue to be a lifeline to so many people living with in these unprecedented times
Reply Retweet Like
NCI Genomics 8h
Single-cell RNA-seq of biopsies before and during targeted therapy of non-small cell patients highlights how therapy-induced adaptation of the tumor ecosystem may shape clinical outcomes
Reply Retweet Like
LungCancerAmerica 4h
Sunday marks the beginning of awareness month! Please join us in our efforts in celebrating those and for !
Reply Retweet Like
Dave Bjork Oct 25
This! 👉 “Lung cancer is the deadliest cancer for women, killing more each year in the U.S. than breast, ovarian, and uterine cancers combined.” - and up to 20% are nonsmokers...
Reply Retweet Like
LUNG FORCE Oct 26
does not stop in the face of a pandemic. If you are a candidate for lung cancer surgery, learn about minimally invasive surgery, which is a type of surgery done with small incisions instead of large cuts.
Reply Retweet Like
Journal of Clinical & Translational Research -JCTR Oct 26
Early identification of patients that fail lung stereotactic body radiation therapy (SBRT) is vital. This review explores the roles and usefulness of 18F-FDG PET/CT for evaluation of tumor response after SBRT for patients:
Reply Retweet Like
Ride Hard Breathe Easy 10h
lung cancer receives only $2,488 per death in federal funding, compared to breast cancer which receives $16,978 per death. Ride Hard Breathe Easy works tirelessly to increase awareness in hopes to increase federal funding.
Reply Retweet Like
Dr. Amy C. Moore Oct 25
Good to see more progress on mutated
Reply Retweet Like
Paperbirds_Oncology 11h
New clinical trial: A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC
Reply Retweet Like
Giants of Cancer Care® Oct 27
Did you know 2019 inductee, David H. Johnson, MD from helped pave the way for the development of multiple drugs for patients with SCLC and NSCLC? Click the link below to learn more about his groundbreaking achievements in !
Reply Retweet Like